nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—Pigmentation disorder—Epirubicin—thyroid cancer	0.0562	0.0562	CcSEcCtD
Molindone—Pigmentation disorder—Doxorubicin—thyroid cancer	0.052	0.052	CcSEcCtD
Molindone—Dysphagia—Vandetanib—thyroid cancer	0.0472	0.0472	CcSEcCtD
Molindone—Gynaecomastia—Sorafenib—thyroid cancer	0.0454	0.0454	CcSEcCtD
Molindone—Weight decreased—Vandetanib—thyroid cancer	0.0427	0.0427	CcSEcCtD
Molindone—Dysphagia—Sorafenib—thyroid cancer	0.0319	0.0319	CcSEcCtD
Molindone—Muscle spasms—Vandetanib—thyroid cancer	0.0316	0.0316	CcSEcCtD
Molindone—Vision blurred—Vandetanib—thyroid cancer	0.031	0.031	CcSEcCtD
Molindone—Tremor—Vandetanib—thyroid cancer	0.0308	0.0308	CcSEcCtD
Molindone—Weight decreased—Sorafenib—thyroid cancer	0.0288	0.0288	CcSEcCtD
Molindone—Dry mouth—Vandetanib—thyroid cancer	0.0274	0.0274	CcSEcCtD
Molindone—Dyspnoea—Vandetanib—thyroid cancer	0.0239	0.0239	CcSEcCtD
Molindone—Constipation—Vandetanib—thyroid cancer	0.023	0.023	CcSEcCtD
Molindone—Amenorrhoea—Epirubicin—thyroid cancer	0.0214	0.0214	CcSEcCtD
Molindone—Muscle spasms—Sorafenib—thyroid cancer	0.0213	0.0213	CcSEcCtD
Molindone—Dyskinesia—Epirubicin—thyroid cancer	0.02	0.02	CcSEcCtD
Molindone—Leukopenia—Sorafenib—thyroid cancer	0.0199	0.0199	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—thyroid cancer	0.0198	0.0198	CcSEcCtD
Molindone—Dry mouth—Sorafenib—thyroid cancer	0.0185	0.0185	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—thyroid cancer	0.0185	0.0185	CcSEcCtD
Molindone—Salivary hypersecretion—Epirubicin—thyroid cancer	0.0182	0.0182	CcSEcCtD
Molindone—Rash—Vandetanib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Molindone—Dermatitis—Vandetanib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.0169	0.0169	CcSEcCtD
Molindone—Dyspnoea—Sorafenib—thyroid cancer	0.0162	0.0162	CcSEcCtD
Molindone—Nausea—Vandetanib—thyroid cancer	0.016	0.016	CcSEcCtD
Molindone—Constipation—Sorafenib—thyroid cancer	0.0155	0.0155	CcSEcCtD
Molindone—Dysphagia—Epirubicin—thyroid cancer	0.0118	0.0118	CcSEcCtD
Molindone—Rash—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Molindone—Dermatitis—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—thyroid cancer	0.0109	0.0109	CcSEcCtD
Molindone—Nausea—Sorafenib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Molindone—Weight increased—Epirubicin—thyroid cancer	0.0107	0.0107	CcSEcCtD
Molindone—Weight decreased—Epirubicin—thyroid cancer	0.0107	0.0107	CcSEcCtD
Molindone—Drowsiness—Epirubicin—thyroid cancer	0.0105	0.0105	CcSEcCtD
Molindone—Weight increased—Doxorubicin—thyroid cancer	0.00991	0.00991	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—thyroid cancer	0.00986	0.00986	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—thyroid cancer	0.00971	0.00971	CcSEcCtD
Molindone—Muscle spasms—Epirubicin—thyroid cancer	0.00789	0.00789	CcSEcCtD
Molindone—Vision blurred—Epirubicin—thyroid cancer	0.00773	0.00773	CcSEcCtD
Molindone—Agitation—Epirubicin—thyroid cancer	0.00754	0.00754	CcSEcCtD
Molindone—Leukopenia—Epirubicin—thyroid cancer	0.00734	0.00734	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—thyroid cancer	0.0073	0.0073	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—thyroid cancer	0.00715	0.00715	CcSEcCtD
Molindone—Agitation—Doxorubicin—thyroid cancer	0.00698	0.00698	CcSEcCtD
Molindone—Dry mouth—Epirubicin—thyroid cancer	0.00683	0.00683	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—thyroid cancer	0.00679	0.00679	CcSEcCtD
Molindone—Tachycardia—Epirubicin—thyroid cancer	0.00653	0.00653	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—thyroid cancer	0.00632	0.00632	CcSEcCtD
Molindone—Hypotension—Epirubicin—thyroid cancer	0.00626	0.00626	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—thyroid cancer	0.00605	0.00605	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—thyroid cancer	0.00597	0.00597	CcSEcCtD
Molindone—Somnolence—Epirubicin—thyroid cancer	0.00595	0.00595	CcSEcCtD
Molindone—Hypotension—Doxorubicin—thyroid cancer	0.00579	0.00579	CcSEcCtD
Molindone—Constipation—Epirubicin—thyroid cancer	0.00573	0.00573	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—thyroid cancer	0.00552	0.00552	CcSEcCtD
Molindone—Somnolence—Doxorubicin—thyroid cancer	0.00551	0.00551	CcSEcCtD
Molindone—Constipation—Doxorubicin—thyroid cancer	0.0053	0.0053	CcSEcCtD
Molindone—Rash—Epirubicin—thyroid cancer	0.00422	0.00422	CcSEcCtD
Molindone—Dermatitis—Epirubicin—thyroid cancer	0.00422	0.00422	CcSEcCtD
Molindone—Nausea—Epirubicin—thyroid cancer	0.00398	0.00398	CcSEcCtD
Molindone—Rash—Doxorubicin—thyroid cancer	0.00391	0.00391	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—thyroid cancer	0.0039	0.0039	CcSEcCtD
Molindone—Nausea—Doxorubicin—thyroid cancer	0.00368	0.00368	CcSEcCtD
